Omnaris

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Ciclesonide 50ug (per actuation)

Disponible depuis:

Chiesi New Zealand Limited t/a Emerge Health

DCI (Dénomination commune internationale):

Ciclesonide 50 µg (per actuation)

Dosage:

50 mcg/dose

forme pharmaceutique:

Nasal spray solution

Composition:

Active: Ciclesonide 50ug (per actuation) Excipient: Carmellose sodium Disodium edetate Hydrochloric acid Hypromellose Microcrystalline cellulose Nitrogen Potassium sorbate Purified water

Unités en paquet:

Inhaler, metered, Glass bottle with metered dose pump, 60 dose units

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

Dynamit Nobel GmbH

indications thérapeutiques:

Omnaris® Nasal Spray is indicated for the treatment of seasonal allergic rhinitis in adults and children 6 years of age and older.

Descriptif du produit:

Package - Contents - Shelf Life: Inhaler, metered, Glass bottle with metered dose pump - 60 dose units - 2 years from date of manufacture stored at or below 30°C. Unopened 4 months opened, Not Specified - Inhaler, metered, Glass bottle with metered dose pump - 120 dose units - 2 years from date of manufacture stored at or below 30°C. Unopened 4 months opened, Not Specified

Date de l'autorisation:

2010-06-28